---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-069992"
form_type: "8-K"
ticker: "MIST"
cik: "0001408443"
company_name: "Milestone Pharmaceuticals Inc."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T03:40:52.541156+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Milestone Pharmaceuticals holds 2023 annual meeting; all director nominees elected

## Summary
- All seven director nominees elected with substantial votes for; highest withheld was Robert J. Wills with 1,317,985 withheld.
- PricewaterhouseCoopers LLP appointed as auditor for the Company with 23,410,435 votes for and 41,638 withheld.
- Broker non-votes ranged from 9,626,977 to 9,626,978 per director nominee.
- Meeting held virtually on June 7, 2023; proposals described in proxy statement filed April 28, 2023.

## SEC filing metadata
- accession: 0001104659-23-069992
- form_type: 8-K
- ticker: MIST
- cik: 0001408443
- company_name: Milestone Pharmaceuticals Inc.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1408443/000110465923069992/0001104659-23-069992-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1408443/000110465923069992/tm2318330d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-069992
- JSON: https://secwatch.observer/filing/0001104659-23-069992.json
- Plain text: https://secwatch.observer/filing/0001104659-23-069992.txt

## Key facts
- Shareholder Votes
  Milestone Pharmaceuticals Inc. shareholders approved Election of Directors at the 2023-06-07 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-07
  source text: Proposal 1. Election of Directors The Company’s shareholders elected the nominees below to the Company’s Board of Directors, each to hold office until the 2024 Annual Meeting of Shareholders or until their successors are duly elected or appointed, or until such directors' earlier resignation or removal. The votes regarding the election of directors were as follows: Nominee Votes For Votes Withheld Broker Non-Votes Joseph Oliveto 13,813,727 11,369 9,626,977 Lisa M. Giles 13,781,817 43,279 9,626,977 Richard Pasternak 13,814,167 10,929 9,626,977 Debra K. Liebert 13,783,097 41,999 9,626,977 Michael Tomsicek 13,813,927 11,168 9,626,978 Robert J. Wills 12,507,111 1,317,985 9,626,977 Seth H.Z. Fischer 13,426,032 399,064 9,626,977
  evidence_url: https://www.sec.gov/Archives/edgar/data/1408443/000110465923069992/0001104659-23-069992-index.htm
- Shareholder Votes
  Milestone Pharmaceuticals Inc. shareholders approved Appointment of PricewaterhouseCoopers LLP as auditor at the 2023-06-07 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-07
  source text: Proposal 2. Appointment of the Company’s Auditor Proposal 2 was a proposal to approve the appointment of PricewaterhouseCoopers LLP as the auditor for the Company to hold office until the close of the 2024 Annual Meeting of Shareholders and the authorization of the Board to fix the auditor's remuneration. The votes regarding the appointment of the Company’s auditor were as follows: Votes For Votes Withheld 23,410,435 41,638
  evidence_url: https://www.sec.gov/Archives/edgar/data/1408443/000110465923069992/0001104659-23-069992-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.